[1]余建忠,施伟,赵瑞,等.儿童髓母细胞瘤的临床特点及预后相关因素分析[J].临床小儿外科杂志,2020,19(03):236-240,247.[doi:10.3969/j.issn.1671-6353.2020.03.009]
 Yu Jianzhong,Shi Wei,Zhao Rui,et al.Clinical characteristics and prognostic factors of pediatric medulloblastoma[J].Journal of Clinical Pediatric Surgery,2020,19(03):236-240,247.[doi:10.3969/j.issn.1671-6353.2020.03.009]
点击复制

儿童髓母细胞瘤的临床特点及预后相关因素分析

参考文献/References:

1 Northcott PA,Robinson GW,Kratz CP,et al.Medulloblastoma[J].Nat Rev Dis Primers,2019,5(1):11.
2 Ramaswamy V,Remke M,Bouffet E,et al.Risk stratification of childhood medulloblastoma in the molecular era:the current consensus[J].Acta Neuropathologica,2016,131(6):821-831.DOI:10.1007/s00401-016-1569-6.
3 Gerber NU,Mynarek M,Von Hoff K,et al.Recent developments and current concepts in medulloblastoma[J].Cancer Treatment Reviews,2014,40(3):356-365.DOI:10.1016/j.ctrv.2013.11.010.
4 Wen PY,Huse JT.2016 World Health Organization Classification of Central Nervous System Tumors[J].CONTINUUM Lifelong Learning in Neurology,2017,23(6):1531-1547.DOI:10.1212/CON.0000000000000536.
5 Juraschka K,Taylor MD.Medulloblastoma in the age of molecular subgrouPs:a review[J].J Neurosurg Pediatr,2019,24(4):353-363.
6 Quinlan,Alyssa,Rizzolo,et al.Understanding medulloblastoma[J].Journal of the American Academy of Physician Assistants,2017,30(10):30-36.
7 Nalita N,Ratanalert S,Kanjanapradit K,et al.Survival and Prognostic Factors in Pediatric Patients with Medulloblastoma in Southern Thailand[J].J Pediatr Neurosci,2018,13(2):150-157.
8 Massimino M,Biassoni V,Gandola L,et al.Childhood me-dulloblastoma[J].Crit Rev Oncol Hematol,2016,105:35-51.DOI:10.1016/j.critrevonc.2016.05.012.
9 Weil MD,Lamborn K,Edwards MS,et al.Influence of a chi-ld’s sex on medulloblastoma outcome[J].Jama the Journal of the American Medical Association,1998,279(18):1474-1476.
10 Sarkar C,Pramanik P,Karak AK,et al.Are childhood and adult medulloblastomas different? A comParative study of clinicoPathological features,Proliferation index and aPoPtotic index[J].J Neurooncol,2002,59(1):49-61.DOI:10.1023/a:1016357731363.
11 Schneider C,Ramaswamy V,Kulkarni AV,et al.Clinical implications of medulloblastoma subgroups:incidence of CSF diversion surgery[J].J Neurosurg Pediatr,2015,15(3):236-242.
12 Archer TC,Mahoney EL,Pomeroy SL.Medulloblastoma:Molecular Classification-Based Personal Therapeutics[J].Neurotherapeutics,2017,14(2):265-273.DOI:10.1007/s13311-017-0526-y.
13 Bokun J,Grujicic D,Skender-Gazibara M,et al.Management and treatment of children with medulloblastoma in Serbia,a middle-income country[J].J BUON,2018,23(4):1156-1162.
14 Khatua S,Song A,Sridhar DC,et al.Childhood Medulloblastoma:Current TheraPies,Emerging Molecular LandscaPe and Newer TheraPeutic Insights[J].Curr NeuroPharmacol,2017,16(7):1045-1058.DOI:10.2174/1570159X15666171129111324.
15 Modha A,Vassilyadi M,George A,et al.Medulloblastoma in children-the Ottawa exPerience[J].Childs Nerv Syst,2000,16(6):341-350.DOI:10.1007/s003810050529.
16 Rickert CH.Abdominal metastases of Pediatric brain tumors via ventriculo-Peritoneal shunts[J].Childs Nerv Syst,1998,14(1-2):10-14.DOI:10.1007/s003810050166.
17 Teklemariam DG,Minyahil A,Yirga L,et al.Treatment of ventriculoperitoneal shunt infection and ventriculitis caused by Acinetobacter baumannii:a case report[J].Journal of Medical Case Reports,2018,12(1):141.DOI:10.1186/s13256-018-1680-5.
18 Nygaard R,Kivivuori SM.Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy[J].Anti-Cancer Drugs,2012,23(3):342-346.DOI:10.1097/cad.0b013e32834ee315.
19 Garzia L,Kijima N,Morrissy AS,et al.A Hematogenous Route for Medulloblastoma LePtomeningeal Metastases[J].Cell,2018,173(6):1549.DOI:10.1016/j.cell.2018.01.038.
20 Kiltie AE,Lashford LS,Gattamaneni HR.Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old[J].Medical and pediatric oncology,1997,28(5):348-354.DOI:10.1002/(sici)1096-911x(199705)28:5<348::aid-mpo4>3.0.co;2-h.

相似文献/References:

[1]李伟清,董子龙,陈乾.髓母细胞瘤分子分型及危险分层的研究进展[J].临床小儿外科杂志,2021,20(07):687.[doi:10.12260/lcxewkzz.2021.07.018]
 Li Weiqing,Dong Zilong,Chen Qian.Research advances in molecular subgroups and risk stratifications of medulloblastoma[J].Journal of Clinical Pediatric Surgery,2021,20(03):687.[doi:10.12260/lcxewkzz.2021.07.018]

备注/Memo

收稿日期:2019-12-05。
基金项目:上海市卫生和计划生育委员会科研课题(青年项目)(编号:20164Y0086);上海市抗癌协会青年医生"雏鹰"项目(编号:SACA-CY1C03)
通讯作者:李昊,Email:lihao7272@163.com

更新日期/Last Update: 1900-01-01